oncology medicine targeted therapy btk inhibitor

💊 Ibrunat 140 mg Capsule | Ibrutinib | Leukemia & Lymphoma Treatment | Export Supplier Ibrunat 140 mg Capsule contains Ibrutinib, a targeted anticancer medicine used in the treatment of chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It works by inhibiting Bruton's tyrosine kinase (BTK), helping to block cancer cell growth and survival. 🔹 Product Category Oncology Medicine (Targeted Therapy / BTK Inhibitor) 🔹 Composition Ibrutinib 140 mg 🔹 Indications ✔ Chronic Lymphocytic Leukemia (CLL) ✔ Mantle Cell Lymphoma (MCL) ✔ Waldenström’s Macroglobulinemia 🔹 Key Benefits ✔ Advanced targeted therapy (BTK inhibitor) ✔ Effective in relapsed & advanced cases ✔ Oral capsule (easy administration) ✔ Widely used in hematology oncology 🔹 Dosage & Administration ✔ Oral capsule as prescribed ✔ Usually taken once daily ✔ Dosage based on treatment protocol ✔ Under strict medical supervision 🔹 Packaging ✔ Bottle / Blister Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Chicago, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com

💊 Ibrunat 140 mg Capsule | Ibrutinib | Leukemia & Lymphoma Treatment | Export Supplier Ibrunat 140 mg Capsule contains Ibrutinib, a targeted anticancer medicine used in the treatment of chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and other B-cell malignancies. It works by inhibiting Bruton's tyrosine kinase (BTK), helping to stop cancer cell growth and survival. 🔹 Product Category Oncology Medicine (Targeted Therapy / BTK Inhibitor) 🔹 Composition Ibrutinib 140 mg 🔹 Indications ✔ Chronic Lymphocytic Leukemia (CLL) ✔ Mantle Cell Lymphoma (MCL) ✔ Waldenström’s Macroglobulinemia 🔹 Key Benefits ✔ Targeted therapy (BTK inhibitor) ✔ Effective in relapsed and advanced cases ✔ Oral capsule (patient-friendly) ✔ Widely used in hematology oncology 🔹 Dosage & Administration ✔ Oral capsule as prescribed ✔ Taken once daily ✔ Dosage based on treatment protocol ✔ Under strict medical supervision 🔹 Packaging ✔ Bottle / Blister Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Chicago, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com